4//SEC Filing
Vollins James 4
Accession 0001103021-21-000020
CIK 0001103021other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:46 PM ET
Size
7.3 KB
Accession
0001103021-21-000020
Insider Transaction Report
Form 4
Vollins James
See Remarks
Transactions
- Sale
Common Stock
2021-02-08$4.16/sh−3,833$15,945→ 0 total - Sale
Common Stock
2021-02-04$3.97/sh−8,303$32,963→ 3,833 total
Footnotes (4)
- [F1]The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan.
- [F2]On February 4, 2021, the Reporting Person sold an aggregate of 8,303 shares of the Issuer's Common Stock at a weighted average price of $3.97 per share. The highest sale price for the Common Stock was $4.02 per share and the lowest sale price was $3.94 per share.
- [F3]The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
- [F4]On February 8, 2021, the Reporting Person sold an aggregate of 3,833 shares of the Issuer's Common Stock at a weighted average price of $4.16 per share. The highest sale price for the Common Stock was $4.18 per share and the lowest sale price was $4.16 per share.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001757833
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 5:46 PM ET
- Size
- 7.3 KB